• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

滤泡性淋巴瘤细胞龛的阴阳两面:微环境异质性和可塑性的作用。

The yin and the yang of follicular lymphoma cell niches: role of microenvironment heterogeneity and plasticity.

机构信息

INSERM, UMR U917, Equipe Labellisée Ligue Contre le Cancer, Faculté de Médecine, Rennes, France; Université Rennes 1, Rennes, France; CHU de Rennes, Hôpital Pontchaillou, Service ITeCH, Pôle de Biologie, Rennes, France.

INSERM, UMR U917, Equipe Labellisée Ligue Contre le Cancer, Faculté de Médecine, Rennes, France; Université Rennes 1, Rennes, France; CHU de Rennes, Hôpital Pontchaillou, Service ITeCH, Pôle de Biologie, Rennes, France; Etablissement Français du Sang Bretagne, Rennes, France.

出版信息

Semin Cancer Biol. 2014 Feb;24:23-32. doi: 10.1016/j.semcancer.2013.08.001. Epub 2013 Aug 23.

DOI:10.1016/j.semcancer.2013.08.001
PMID:23978491
Abstract

Follicular lymphoma (FL) results from the malignant transformation of germinal center B cells and is characterized by recurrent genetic alterations providing a direct growth advantage or facilitating interaction with tumor microenvironment. In agreement, accumulating evidences suggest a dynamic bidirectional crosstalk between FL B cells and surrounding non-malignant cells within specialized tumor niches in both invaded lymph nodes and bone marrow. Infiltrating stromal cells, macrophages, and T/NK cell subsets either contribute to anti-tumor immune response, or conversely form a tumor supportive network promoting FL B cell survival, growth, and drug resistance. This review depicts the phenotypic heterogeneity and functional plasticity of the most important FL cell partners and describes their complex interplay. We also unravel how malignant B cells recruit and subvert accessory immune and stromal cells to trigger their polarization toward a supportive phenotype. Based on these observations, innovative therapeutic approaches have been recently proposed, in order to benefit from local anti-tumor immunity and/or to selectively target the protective cell niche.

摘要

滤泡性淋巴瘤 (FL) 源于生发中心 B 细胞的恶性转化,其特征是反复出现的遗传改变提供了直接的生长优势或促进与肿瘤微环境的相互作用。一致地,越来越多的证据表明,FL B 细胞与在入侵淋巴结和骨髓中的特定肿瘤龛内的周围非恶性细胞之间存在动态双向串扰。浸润的基质细胞、巨噬细胞和 T/NK 细胞亚群要么有助于抗肿瘤免疫反应,要么相反形成促进 FL B 细胞存活、生长和耐药性的肿瘤支持网络。这篇综述描绘了最重要的 FL 细胞伙伴的表型异质性和功能可塑性,并描述了它们的复杂相互作用。我们还揭示了恶性 B 细胞如何招募和颠覆辅助免疫和基质细胞,以触发它们向支持性表型的极化。基于这些观察结果,最近提出了创新的治疗方法,以便利用局部抗肿瘤免疫和/或选择性地靶向保护性细胞龛。

相似文献

1
The yin and the yang of follicular lymphoma cell niches: role of microenvironment heterogeneity and plasticity.滤泡性淋巴瘤细胞龛的阴阳两面:微环境异质性和可塑性的作用。
Semin Cancer Biol. 2014 Feb;24:23-32. doi: 10.1016/j.semcancer.2013.08.001. Epub 2013 Aug 23.
2
Neutrophils trigger a NF-κB dependent polarization of tumor-supportive stromal cells in germinal center B-cell lymphomas.中性粒细胞在生发中心B细胞淋巴瘤中引发肿瘤支持性基质细胞的NF-κB依赖性极化。
Oncotarget. 2015 Jun 30;6(18):16471-87. doi: 10.18632/oncotarget.4106.
3
Functional alteration of the lymphoma stromal cell niche by the cytokine context: role of indoleamine-2,3 dioxygenase.细胞因子环境对淋巴瘤基质细胞生态位的功能改变:吲哚胺-2,3-双加氧酶的作用
Cancer Res. 2009 Apr 1;69(7):3228-37. doi: 10.1158/0008-5472.CAN-08-3000. Epub 2009 Mar 10.
4
The microenvironment in follicular lymphoma.滤泡性淋巴瘤的微环境。
Best Pract Res Clin Haematol. 2011 Jun;24(2):135-46. doi: 10.1016/j.beha.2011.02.007. Epub 2011 May 17.
5
IL-4/CXCL12 loop is a key regulator of lymphoid stroma function in follicular lymphoma.IL-4/CXCL12 循环是滤泡性淋巴瘤中淋巴样基质功能的关键调节因子。
Blood. 2017 May 4;129(18):2507-2518. doi: 10.1182/blood-2016-08-737239. Epub 2017 Feb 15.
6
Impact of B cell/lymphoid stromal cell crosstalk in B-cell physiology and malignancy.B 细胞/淋巴间质细胞相互作用对 B 细胞生理学和恶性肿瘤的影响。
Immunol Lett. 2019 Nov;215:12-18. doi: 10.1016/j.imlet.2019.02.005. Epub 2019 Mar 4.
7
Stromal cell contribution to human follicular lymphoma pathogenesis.基质细胞对人类滤泡性淋巴瘤发病机制的贡献。
Front Immunol. 2012 Sep 5;3:280. doi: 10.3389/fimmu.2012.00280. eCollection 2012.
8
Cell cross talk within the lymphoma tumor microenvironment: follicular lymphoma as a paradigm.淋巴瘤肿瘤微环境中的细胞串扰:以滤泡性淋巴瘤为例。
Blood. 2024 Mar 21;143(12):1080-1090. doi: 10.1182/blood.2023021000.
9
Bone Marrow Lymphoid Niche Adaptation to Mature B Cell Neoplasms.骨髓淋巴样龛适应成熟 B 细胞肿瘤。
Front Immunol. 2021 Dec 8;12:784691. doi: 10.3389/fimmu.2021.784691. eCollection 2021.
10
Extracellular vesicles shed by follicular lymphoma B cells promote polarization of the bone marrow stromal cell niche.滤泡性淋巴瘤 B 细胞释放的细胞外囊泡促进骨髓基质细胞龛的极化。
Blood. 2021 Jul 8;138(1):57-70. doi: 10.1182/blood.2020008791.

引用本文的文献

1
Lymphoma B cells remodel bone marrow stromal cells into extracellular matrix-producing cancer-associated fibroblasts.淋巴瘤B细胞将骨髓基质细胞重塑为产生细胞外基质的癌症相关成纤维细胞。
Blood Adv. 2025 Jul 22;9(14):3455-3468. doi: 10.1182/bloodadvances.2024015616.
2
Deep immunophenotypic dissection and clinical impact of T cells in the follicular lymphoma microenvironment.滤泡性淋巴瘤微环境中T细胞的深度免疫表型剖析及其临床影响
Haematologica. 2025 Aug 1;110(8):1808-1821. doi: 10.3324/haematol.2024.286383. Epub 2025 Feb 6.
3
Development of patient-derived lymphomoids with preserved tumor architecture for lymphoma therapy screening.
用于淋巴瘤治疗筛选的具有保留肿瘤结构的患者源性类淋巴瘤的开发。
Nat Commun. 2024 Dec 9;15(1):10650. doi: 10.1038/s41467-024-55098-w.
4
Patient-derived follicular lymphoma spheroids recapitulate lymph node signaling and immune profile uncovering galectin-9 as a novel immunotherapeutic target.患者来源的滤泡性淋巴瘤球体重现淋巴结信号传导和免疫特征,揭示半乳凝素-9作为一种新的免疫治疗靶点。
Blood Cancer J. 2024 May 2;14(1):75. doi: 10.1038/s41408-024-01041-7.
5
Patient-derived lymphoma spheroids integrating immune tumor microenvironment as preclinical follicular lymphoma models for personalized medicine.患者来源的淋巴瘤球体整合免疫肿瘤微环境作为个体化医学的滤泡性淋巴瘤临床前模型。
J Immunother Cancer. 2023 Oct;11(10). doi: 10.1136/jitc-2023-007156.
6
The Yin-Yang Dynamics in Cancer Pharmacogenomics and Personalized Medicine.癌症药物基因组学和个性化医学中的阴阳动态。
Methods Mol Biol. 2022;2547:141-163. doi: 10.1007/978-1-0716-2573-6_6.
7
Unveiling the Role of the Tumor Microenvironment in the Treatment of Follicular Lymphoma.揭示肿瘤微环境在滤泡性淋巴瘤治疗中的作用
Cancers (Basel). 2022 Apr 26;14(9):2158. doi: 10.3390/cancers14092158.
8
Bone Marrow Lymphoid Niche Adaptation to Mature B Cell Neoplasms.骨髓淋巴样龛适应成熟 B 细胞肿瘤。
Front Immunol. 2021 Dec 8;12:784691. doi: 10.3389/fimmu.2021.784691. eCollection 2021.
9
Immunomodulatory Drugs for the Treatment of B Cell Malignancies.免疫调节药物治疗 B 细胞恶性肿瘤。
Int J Mol Sci. 2021 Aug 9;22(16):8572. doi: 10.3390/ijms22168572.
10
Obinutuzumab-atezolizumab-lenalidomide for the treatment of patients with relapsed/refractory follicular lymphoma: final analysis of a Phase Ib/II trial.奥妥珠单抗-阿替利珠单抗-来那度胺治疗复发/难治性滤泡性淋巴瘤患者:Ib/II期试验的最终分析
Blood Cancer J. 2021 Aug 20;11(8):147. doi: 10.1038/s41408-021-00539-8.